Liquid versus tissue biopsy for detecting actionable alterations according to ESCAT in patients with advanced cancer: A study from the French National Center for Precision Medicine (PRISM)

Metrics

[tpsingle id= »19″]

[tpabstract id= »19″]

Prism center is a one-of-a-kind partnership between

Prism IHU-B

Bâtiment de médecine moléculaire

32 Rue Camille Desmoulins

94800 Villejuif

Tél. +33(0)1 42 11 00 00

info -at- prism.center

Presse

Rejoindre nos équipes

Appels à projets

Accessibilité

Les cookies

Mentions légales







